Home
About
Overview
Sharing Data
ORCID
Help
History (53)
Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials.
Management of inflammatory bowel disease: past, present and future.
Atopic and non-atopic effects of fish oil supplementation during pregnancy.
Postpartum Contraception Use by Urban/Rural Status: An Analysis of the Michigan Pregnancy Risk Assessment Monitoring System Data.
Briakinumab for treatment of Crohn's disease: results of a randomized trial.
See All 53 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Briakinumab for treatment of Crohn's disease: results of a randomized trial.
Briakinumab for treatment of Crohn's disease: results of a randomized trial. Inflamm Bowel Dis. 2015 Jun; 21(6):1329-40.
View in:
PubMed
subject areas
Adult
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Crohn Disease
Double-Blind Method
Female
Humans
Interleukin-12 Subunit p40
Male
Middle Aged
Remission Induction
Time Factors
Tumor Necrosis Factor-alpha
authors with profiles
Stephen B. Hanauer